TD Asset Management
HAE icon

TD Asset Management’s Haemonetics HAE Stock Holding History

TD Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,030
Closed -$1.49M – 1257
2025
Q2 		$1.49M Sell
20,030
-9,388
-32% -$622K ﹤0.01% 1000
2025
Q1 		$1.87M Sell
29,418
-25,802
-47% -$1.75M ﹤0.01% 980
2024
Q4 		$4.31M Sell
55,220
-6,000
-10% -$482K ﹤0.01% 821
2024
Q3 		$4.89M Buy
61,220
+29,574
+93% +$2.39M ﹤0.01% 806
2024
Q2 		$2.62M Sell
31,646
-20,800
-40% -$1.83M ﹤0.01% 917
2024
Q1 		$4.48M Buy
52,446
+25,400
+94% +$1.99M ﹤0.01% 798
2023
Q4 		$2.31M Buy
27,046
+3,446
+15% +$298K ﹤0.01% 963
2023
Q3 		$2.11M Buy
+23,600
New +$2.11M ﹤0.01% 940

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TD Asset Management's HAE Position: Q3 2025 in Review

TD Asset Management sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 20,030 shares — an estimated $1.49M sold.

TD Asset Management first reported a position in HAE in Q3 2023 and held it in 8 quarters. The position peaked at $4.89M in Q3 2024. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • TD Asset Management reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
  • TD Asset Management sold 20,030 Haemonetics shares in Q3 2025, an estimated $1.49M.
  • TD Asset Management first reported a position in Haemonetics in Q3 2023 and held it in 8 quarters.
  • TD Asset Management's Haemonetics position peaked at $4.89M in Q3 2024.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on TD Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.